Literature DB >> 21487939

OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16.

Fandou Kong1, Rui Tong, Lingyu Jia, Wei Wei, Xiaoyan Miao, Xinyu Zhao, Wenping Sun, Guang Yang, Chunyan Zhao.   

Abstract

OVCA1, a tumor suppressor gene, is deleted or lower expressed in about 80% of ovarian cancer. Over expression of OVCA1 in human ovarian cancer A2780 cells inhibits cell proliferation and arrests cells in G1 stage. However, the fact that the molecular mechanism of OVCA1 inhibits cell growth is presently elusive. Here we investigated the potential signaling pathway induced by over-expression of OVCA1. Our results show that over-expression of human OVCA1 in ovarian cancer cells A2780 leads to down-regulation of cyclin D1, and up-regulation of p16, but no effect on the expression of NF-κB. It indicates that OVCA1 could inhibit the proliferation of ovarian cancer cell A2780 by p16/cyclin D1 pathway, but not by NF-κB.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487939     DOI: 10.1007/s11010-011-0819-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation.

Authors:  Suzana Atanasoski; Danielle Boller; Lukas De Ventura; Heidi Koegel; Matthias Boentert; Peter Young; Sabine Werner; Ueli Suter
Journal:  Glia       Date:  2006-01-15       Impact factor: 7.452

3.  The Akt pathway in human breast cancer: a tissue-array-based analysis.

Authors:  Shikha Bose; Sindhu Chandran; James M Mirocha; Namrata Bose
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

4.  Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression.

Authors:  Bharathi Ramdass; Tessy T Maliekal; S Lakshmi; Michael Rehman; P Rema; Pradip Nair; Geetashree Mukherjee; B K M Reddy; Sudhir Krishna; M Radhakrishna Pillai
Journal:  Gynecol Oncol       Date:  2006-11-13       Impact factor: 5.482

Review 5.  NF-kappaB: tumor promoter or suppressor?

Authors:  Neil D Perkins
Journal:  Trends Cell Biol       Date:  2004-02       Impact factor: 20.808

6.  Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.

Authors:  D W Wiper; K M Zanotti; A W Kennedy; J L Belinson; G Casey
Journal:  Gynecol Oncol       Date:  1998-10       Impact factor: 5.482

7.  Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2.

Authors:  D C Schultz; B R Balasara; J R Testa; A K Godwin
Journal:  Genomics       Date:  1998-09-01       Impact factor: 5.736

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.

Authors:  Chun-Ming Chen; Richard R Behringer
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

10.  Identification of two candidate tumor suppressor genes on chromosome 17p13.3.

Authors:  D C Schultz; L Vanderveer; D B Berman; T C Hamilton; A J Wong; A K Godwin
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

View more
  8 in total

1.  Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.

Authors:  Nils J Fredriksson; Lars Ny; Jonas A Nilsson; Erik Larsson
Journal:  Nat Genet       Date:  2014-11-10       Impact factor: 38.330

2.  Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde.

Authors:  Amin Sobh; Alex Loguinov; Alessia Stornetta; Silvia Balbo; Abderrahmane Tagmount; Luoping Zhang; Chris D Vulpe
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

3.  Low-temperature Plasma Promotes Fibroblast Proliferation in Wound Healing by ROS-activated NF-κB Signaling Pathway.

Authors:  Xing-Min Shi; Gui-Min Xu; Guan-Jun Zhang; Jin-Ren Liu; Yue-Ming Wu; Ling-Ge Gao; Yang Yang; Zheng-Shi Chang; Cong-Wei Yao
Journal:  Curr Med Sci       Date:  2018-03-15

4.  Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.

Authors:  Alexander Pemov; Heejong Sung; Paula L Hyland; Jennifer L Sloan; Sarah L Ruppert; Andrea M Baldwin; Joseph F Boland; Sara E Bass; Hyo Jung Lee; Kristine M Jones; Xijun Zhang; James C Mullikin; Brigitte C Widemann; Alexander F Wilson; Douglas R Stewart
Journal:  PLoS Genet       Date:  2014-10-16       Impact factor: 5.917

5.  OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.

Authors:  Rui Tong; Qing Yang; Chunyan Wang; Fangfang Bi; Bing Jiang
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

6.  A mutated dph3 gene causes sensitivity of Schizosaccharomyces pombe cells to cytotoxic agents.

Authors:  Desirée Villahermosa; Karen Knapp; Oliver Fleck
Journal:  Curr Genet       Date:  2017-05-29       Impact factor: 3.886

Review 7.  The biosynthesis and biological function of diphthamide.

Authors:  Xiaoyang Su; Zhewang Lin; Hening Lin
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-08-23       Impact factor: 8.697

8.  Comparative analysis of the human serine hydrolase OVCA2 to the model serine hydrolase homolog FSH1 from S. cerevisiae.

Authors:  Jessica S Bun; Michael D Slack; Daniel E Schemenauer; R Jeremy Johnson
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.